Company / SG&A per Share
Ginkgo Bioworks Holdings, Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.37
FY2025
5-year range
$0.20 / $4.92
FY2021-FY2025
Trend
-31.5%
vs FY2024
Sector context
#51 of 208
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s sg&a per share of $3.37 is higher than 75% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 7 years, ranging from $0.03 in FY2019 to $4.92 in FY2024.
Based on SEC 10-K filings.
3.37 in FY2025 with a 5-year CAGR of +157.0%. Top quartile in the Health Care sector.
Increased from $0.20 to $3.37 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +56.0%
- 5-Year CAGR
- +157.0%
- 10-Year CAGR
- -
Sector benchmark
-88.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 31.5% year-over-year.
- Ranks #51 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.37 | -31.5% |
| FY2024 | $4.92 | +2317.6% |
| FY2023 | $0.20 | -77.1% |
| FY2022 | $0.89 | +32.5% |
| FY2021 | $0.67 | +2128.6% |
| FY2020 | $0.03 | +17.1% |
| FY2019 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026